tiprankstipranks
Advertisement
Advertisement

JP:2395 Stock Latest News

SNBL Corrects Earnings Per Share Figure in Q1 FY2026 Disclosure
Company AnnouncementsSNBL Corrects Earnings Per Share Figure in Q1 FY2026 Disclosure
11d ago
2395
Shin Nippon Biomedical Laboratories Lifts First-Half Earnings Forecast on Strong CRO Performance
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Lifts First-Half Earnings Forecast on Strong CRO Performance
11d ago
2395
SNBL Sets New Management Structure and Highlights FY3/27 Q1 CRO Strategy
PremiumCompany Announcements
SNBL Sets New Management Structure and Highlights FY3/27 Q1 CRO Strategy
11d ago
2395
SNBL Delivers Strong Q1 Earnings and Confirms Dividend Outlook
PremiumCompany Announcements
SNBL Delivers Strong Q1 Earnings and Confirms Dividend Outlook
11d ago
2395
Shin Nippon Biomedical Laboratories Keeps Annual Dividend at ¥50 as CRO Business Hits Record Highs
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Keeps Annual Dividend at ¥50 as CRO Business Hits Record Highs
3M ago
2395
SNBL backs U.S. launch build-out for migraine drug Atzumi after licensing talks stall
PremiumCompany AnnouncementsSNBL backs U.S. launch build-out for migraine drug Atzumi after licensing talks stall
3M ago
2395
Shin Nippon Biomedical Laboratories Outlines FY2026 Results and Strategic Focus
Premium
Company Announcements
Shin Nippon Biomedical Laboratories Outlines FY2026 Results and Strategic Focus
3M ago
2395
SNBL Posts Flat Revenue, Lower Profits but Stronger Balance Sheet and Cash Ahead of FY2027 Growth Push
Premium
Company Announcements
SNBL Posts Flat Revenue, Lower Profits but Stronger Balance Sheet and Cash Ahead of FY2027 Growth Push
3M ago
2395
SNBL to Shift Meeting Leadership to Board Chair in Governance Revamp
PremiumCompany Announcements
SNBL to Shift Meeting Leadership to Board Chair in Governance Revamp
4M ago
2395
SNBL Revamps Top Management to Drive Long-Term Growth
PremiumCompany Announcements
SNBL Revamps Top Management to Drive Long-Term Growth
4M ago
2395
SNBL Releases Q3 FY2026 Results Briefing and Business Update
PremiumCompany Announcements
SNBL Releases Q3 FY2026 Results Briefing and Business Update
6M ago
2395
SNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast Higher
PremiumCompany Announcements
SNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast Higher
6M ago
2395
Shin Nippon Biomedical Laboratories Cuts Earnings Outlook Amid Profit Decline but Maintains Dividend Plan
PremiumCompany AnnouncementsShin Nippon Biomedical Laboratories Cuts Earnings Outlook Amid Profit Decline but Maintains Dividend Plan
6M ago
2395
SNBL Warns of Added Costs as U.S. Migraine Drug Unit Talks Continue
Premium
Company Announcements
SNBL Warns of Added Costs as U.S. Migraine Drug Unit Talks Continue
7M ago
2395
Shin Nippon Biomedical Announces Interim Dividends
Premium
Company Announcements
Shin Nippon Biomedical Announces Interim Dividends
9M ago
2395
Shin Nippon Biomedical Laboratories Exceeds Financial Forecasts for H1 2025
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Exceeds Financial Forecasts for H1 2025
9M ago
2395
Shin Nippon Biomedical Laboratories Reports Increased Revenue but Declining Profits
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Reports Increased Revenue but Declining Profits
9M ago
2395
Shin Nippon Biomedical Laboratories Reports Mixed Financial Results for Q1 2025
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Reports Mixed Financial Results for Q1 2025
1y ago
2395
Shin Nippon Biomedical Laboratories Announces Year-End Dividend
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Announces Year-End Dividend
1y ago
2395
Shin Nippon Biomedical Laboratories Corrects Financial Results for FY 2025
PremiumCompany AnnouncementsShin Nippon Biomedical Laboratories Corrects Financial Results for FY 2025
1y ago
2395
Shin Nippon Biomedical Reports Revenue Growth Amid Profit Decline
Premium
Company Announcements
Shin Nippon Biomedical Reports Revenue Growth Amid Profit Decline
1y ago
2395
Satsuma Pharmaceuticals Gains FDA Approval for Migraine Treatment
Premium
Company Announcements
Satsuma Pharmaceuticals Gains FDA Approval for Migraine Treatment
1y ago
2395

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >